Description
Descripción clínica en INGLÉS: indicaciones en CCR, eficacia general, contexto de uso (3-4 frases)
Mechanism of Action
Mecanismo de acción detallado en INGLÉS (2-3 frases, técnico pero claro)
Side Effects
Efectos secundarios principales en INGLÉS separados por punto y coma
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
NCT06827613
Phase 1
Recruiting
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
United States, Canada
NCT05592626
Phase 1
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
United States, Canada, France, Spain
Quick Info
| Category | Other Medications |
 EMA Status | Not submitted to EMA |
| Clinical Trials | 2 |
Related Medications
Uracil
Other Medications
785 trials
Leucovorin
Other Medications
646 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.